The Effects of Platelet-Rich Plasma on Muscle: Basic Science and Clinical Application

Operative Techniques in Sports Medicine

Volumn 19, Issue 3, 2011, Pages 149-153

  Mejia, Hector A ^a   Bradley, James P ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Burke and Bradley Orthopaedics   (United States)

Author keywords

Growth factors; Hamstring strain; Muscle injuries; Platelet rich plasma; Skeletal muscle

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; PARACETAMOL; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ALGORITHM; ARTICLE; ATHLETE; FOOTBALL; HAMSTRING; HEALING; HUMAN; MODULATION; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE STRAIN; MUSCULOSKELETAL INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRIORITY JOURNAL; SKELETAL MUSCLE; SPORT INJURY; THROMBOCYTE RICH PLASMA;

EID: 80052306485     PISSN: 10601872     EISSN: 15579794     Source Type: Journal    
DOI: 10.1053/j.otsm.2011.04.002     Document Type: Article

References (42)

1. Beiner J.M., Jokl P. Muscle contusion injuries: Current treatment options. J Am Acad Orthop Surg 2001, 9:227M-237.
2. Garrett W.E. Muscle strain injuries. Am J Sports Med 1996, 24(6 suppl):S2-S8.
3. Cole JB, Shane T. Seroyer, Filardo G, et al: Platelet-rich plasma: Where are we now and where are we going? Sports Health: A Multidisciplinary Approach 2:203-210, 2010.
4. Wroblewski P.A., Wright J.V. Application of Platelet-Rich Plasma to Enhance Tissue Repair. Oper Tech Orthop 2010, 20:98-105. MAH.
5. Huang S., Wang Z. Influence of platelet-rich plasma on proliferation and osteogenic differentiation of skeletal muscle satellite cells: An in vitro study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 110:453-462.
6. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
7. Sanchez M., Anitua E., Orive G., et al. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009, 39:345-354.
8. Mishra A., Woodall J., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009, 28:113-125.
9. Mishra A., Tummala P., King A., et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng C Methods 2009, 15:431-435.
10. Jarvinen T.A., Kääriäinen M., Järvinen M., et al. Muscle strain injuries. Curr Opin Rheumatol 2000, 12:155-161.
11. Huard J., Li Y., Fu F.H. Muscle injuries and repair: Current trends in research. J Bone Joint Surg Am 84-A 2002, 822-832.
12. Crisco J.J., Jokl P., Heinen G.T., et al. A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med 1994, 22:702-710.
13. Mishra D.K., Fridén J., Schmitz M.C., et al. Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg Am 1995, 77:1510-1519.
14. Burkin D.J., Kaufman S.J. The alpha7beta1 integrin in muscle development and disease. Cell Tissue Res 1999, 296:183-190.
15. Best T.M., Hunter K.D. Muscle injury and repair. Phys Med Rehabil Clin N Am 2000, 11:251-266.
16. Cannon J.G., St Pierre B.A. Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem 1998, 179:159-167.
17. Aronson D., Wojtaszewski J.F., Thorell A., et al. Extracellular-regulated protein kinase cascades are activated in response to injury in human skeletal muscle. Am J Physiol 1998, 275:C555-C561.
18. Tidball J.G. Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc 1995, 27:1022-1032.
19. Toumi H., Best T.M. The inflammatory response: Friend or enemy for muscle injury?. Br J Sports Med 2003, 37:284-286.
20. Toumi H., F'Guyer S., Best T.M. The role of neutrophils in injury and repair following muscle stretch. J Anat 2006, 208:459-470.
21. Scott A., Khan K.M., Roberts C.R., et al. What do we mean by the term "inflammation"?. A contemporary basic science update for sports medicine. Br J Sports Med 2004, 38:372-380.
22. Pizza F.X., Koh T.J., McGregor S.J., et al. Muscle inflammatory cells after passive stretches, isometric contractions, and lengthening contractions. J Appl Physiol 2002, 92:1873-1878.
23. Dovi J.V., He L.K., DiPietro L.A. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003, 73:448-455.
24. Husmann I., Soulet L., Gautron J., et al. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev 1996, 7:249-258.
25. Kasemkijwattana C., Menetrey J., Bosch P., et al. Use of growth factors to improve muscle healing after strain injury. Clin Orthop Relat Res 2000, 370:272-285.
26. Menetrey J., Kasemkijwattana C., Day C.S., et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg Br 2000, 82:131-137.
27. Bernasconi P., Torchiana E., Confalonieri P., et al. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 1995, 96:1137-1144.
28. Logan A., Berry M., Gonzalez A.M., et al. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 1994, 6:355-363.
29. Terrell T.G., Working P.K., Chow C.P., et al. Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol 1993, 34:43-67.
30. Westergren-Thorsson G., Hernnäs J., Särnstrand B., et al. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993, 92:632-637.
31. Wolf Y.G., Rasmussen L.M., Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994, 93:1172-1178.
32. Yamamoto T., Noble N.A., Miller D.E., et al. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 1994, 45:916-927.
33. Yamazaki M., Minota S., Sakurai H., et al. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am J Pathol 1994, 144:221-226.
34. Smith C.W., Klaasmeyer J.G., Woods T.L., et al. Effects of IGF-I, IGF-II, bFGF and PDGF on the initiation of mRNA translation in C2C12 myoblasts and differentiating myoblasts. Tissue Cell 1999, 31:403-412.
35. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell 1986, 46:155-169.
36. Jin P., Rahm M., Claesson-Welsh L., et al. Expression of PDGF A-chain and beta-receptor genes during rat myoblast differentiation. J Cell Biol 1990, 110:1665-1672.
37. Springer M.L., Chen A.S., Kraft P.E., et al. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol Cell 1998, 2:549-558.
38. Bertrand-Duchesne M.P., Grenier D., Gagnon G. Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferation in vitro. J Periodontal Res 2010, 45:87-93.
39. Kasemkijwattana C., Menetrey J., Somogyl G., et al. Development of approaches to improve the healing following muscle contusion. Cell Transplant 1998, 7:585-598.
40. Hammond J.W., Hinton R.Y., Curl L.A., et al. Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med 2009, 37:1135-1142.
41. Sánchez M., Andía I. Application of autologous growth factors on skeletal muscle healing, in 2nd World Congress on Regenerative Medicine 2005, AE, Leipzig, Germany.
42. Foster T.E., Puskas B.L., Mandelbaum B.R., et al. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med 2009, 37:2259-2272.